Transcriptome and cytogenetic profiling analysis of matched in situ/invasive cutaneous squamous cell carcinomas from immunocompetent patients.


Journal

Genes, chromosomes & cancer
ISSN: 1098-2264
Titre abrégé: Genes Chromosomes Cancer
Pays: United States
ID NLM: 9007329

Informations de publication

Date de publication:
03 2019
Historique:
received: 07 02 2018
revised: 01 11 2018
accepted: 22 11 2018
pubmed: 27 11 2018
medline: 22 3 2019
entrez: 27 11 2018
Statut: ppublish

Résumé

Although most cutaneous squamous cell carcinomas (cSCCs) develop from actinic keratoses (AKs), the key events in this evolution remain unclear. We have combined the results of different genomic and expression array platforms on matched concomitant samples of sun-exposed skin (SES), AK, and cSCC from 10 immunocompetent patients. Gene expression analysis and copy number alterations were assessed using GeneChip Human Gene 2.0 ST Array (Affymetrix, Santa Clara, CA) and CytoScan HD Cytogenetics Solution (Affymetrix) platforms, respectively. Integration of transcriptome and genome results was evaluated using the DR-Integrator tool. Additional studies (qPCR, immunohistochemistry, and Western blot) were performed for selected genes. FOSL1 and BNC1 encode transcription factors whose expression was increased in cSCC in the expression array and the qPCR. By immunohistochemistry, FOSL1 showed an intense staining at the invasive front of cSCC samples and BNC1 expression varied from a nuclear (SES) to a cytoplasmic location (cSCC). Western blot analyses confirmed the enhancement of FOSL1 and BNC1. In addition, the smallest overlapping regions (SORIs) of genomic imbalance involving at least three of the samples were selected. One of the SORIs was a deletion in the p24.1 band of chromosome 3, shared by seven of the cSCCs. A strong correlation in the integration analysis was found for NEK10, a gene contained in the previously mentioned SORI. Loss of NEK10 expression in cSCC was confirmed by immunohistochemistry and Western blot analyses. In addition, functional studies in NEK10 depleted cells were performed. In conclusion, we identified FOSL1 and BNC1, which could act as tumor drivers, and NEK10, which could function as a tumor suppressor, to be differentially expressed during cSCC development.

Identifiants

pubmed: 30474248
doi: 10.1002/gcc.22712
doi:

Substances chimiques

Biomarkers, Tumor 0
DNA-Binding Proteins 0
Proto-Oncogene Proteins c-fos 0
Transcription Factors 0
fos-related antigen 1 0
BNC1 protein, human 148814-46-4
NIMA-Related Kinases EC 2.7.11.1
Nek10 protein, human EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

164-174

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Irene García-Díez (I)

Department of Dermatology, Hospital del Mar, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Group of Inflammatory and Neoplastic Dermatological Diseases, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Inmaculada Hernández-Muñoz (I)

Group of Inflammatory and Neoplastic Dermatological Diseases, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Eugenia Hernández-Ruiz (E)

Department of Dermatology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

Lara Nonell (L)

Microarray Analysis Service, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Eulàlia Puigdecanet (E)

Microarray Analysis Service, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Marta Bódalo-Torruella (M)

Microarray Analysis Service, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Evelyn Andrades (E)

Group of Inflammatory and Neoplastic Dermatological Diseases, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Ramon M Pujol (RM)

Department of Dermatology, Hospital del Mar, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Group of Inflammatory and Neoplastic Dermatological Diseases, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Agustí Toll (A)

Department of Dermatology, Hospital del Mar, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Group of Inflammatory and Neoplastic Dermatological Diseases, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH